Navigation Links
Johnson & Johnson Nordic AB Acquires Amic
Date:6/18/2008

Gains Access to In Vitro Diagnostic Technologies in Development for Use in

Point-of-Care Settings

SOLLENTUNA, Sweden, June 18 /PRNewswire/ -- Johnson & Johnson Nordic AB, a Johnson & Johnson company, today announced the acquisition of Amic, a privately held Swedish developer of in vitro diagnostic (IVD) technologies for use in Point-of-Care (POC) and near-patient settings (outside the physical facilities of the clinical laboratory). The acquisition will provide Ortho-Clinical Diagnostics, Inc., a Johnson & Johnson company, with access to a high performance technology platform -- currently in development in this rapidly growing area of diagnostics -- that complements its clinical laboratory, immunohematology and donor screening businesses. As a result of the acquisition, Johnson & Johnson expects to incur an estimated one-time after-tax charge of approximately $40 million during the second quarter of 2008 related to the expensing of in-process research and development. Other terms of the transaction were not disclosed.

Amic is developing technology that uses a chip-based micro-fluidic platform to enable fully quantitative, immunoassay tests in POC or near-patient settings. This next-generation technology represents an advance in an area of diagnostics where double-digit market growth is anticipated.

"This acquisition is a strategic opportunity to develop a Point-of-Care channel," said Mark Straley, Worldwide Commercial President, Ortho-Clinical Diagnostics, Inc. "We're committed to bringing novel assays and existing tests closer to the patient and delivering information to health care professionals when and where they need it."

"We're excited about the possibilities of touching the lives of patients by combining our testing technologies with current and future assays of Ortho-Clinical Diagnostics," said Ove Ohman, founder and CEO, Amic.

About Johnson & Johnson Nordic AB

Johnson & Johnson Nordic AB is a subsidiary of Johnson & Johnson. Based in Sollentuna, Sweden, Johnson & Johnson Nordic AB is a sales and marketing company in the Medical Devices & Diagnostics segment.

About Ortho-Clinical Diagnostics, Inc.

Ortho-Clinical Diagnostics, Inc., a Johnson & Johnson company, delivers high quality in vitro diagnostic products that give health care professionals around the world the knowledge they need to make better treatment decisions sooner. The company serves the global transfusion medicine community with donor screening and blood typing products to help ensure every patient receives blood that's safe, the right type, and the right unit. Ortho-Clinical Diagnostics also brings sophisticated information management, testing technologies, automation and interpretation tools to clinical laboratories worldwide to help them run more efficiently and improve patient care. For more information, visit http://www.orthoclinical.com.

(This press release contains "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995. These statements are based on current expectations of future events. If underlying assumptions prove inaccurate or unknown risks or uncertainties materialize, actual results could vary materially from Johnson & Johnson's expectations and projections. Risks and uncertainties include general industry conditions and competition; economic conditions, such as interest rate and currency exchange rate fluctuations; technological advances and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approvals; domestic and foreign health care reforms and governmental laws and regulations; and trends toward health care cost containment. A further list and description of these risks, uncertainties and other factors can be found in Exhibit 99 of the Company's Annual Report on Form 10-K for the fiscal year ended December 30, 2007. Copies of this Form 10-K, as well as subsequent filings, are available online at http://www.sec.gov, http://www.jnj.com or on request from Johnson & Johnson. Johnson & Johnson does not undertake to update any forward-looking statements as a result of new information or future events or developments.)


'/>"/>
SOURCE Johnson & Johnson Nordic AB
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Johnson & Johnson and American Red Cross Announce Resolution of Lawsuit
2. The Robert Wood Johnson Foundation and the Center For Creative Leadership Launch National Training Program for Nonprofit Leaders
3. Now Playing: Spike Lee Stands with Earvin Magic Johnson, Cookie Johnson and Abbott to Launch National PSA Campaign
4. Johnson & Johnson Reviews Growth Strategies for Medical Devices & Diagnostics and Consumer Businesses
5. Johnson & Johnson to Host Medical Devices & Diagnostics and Consumer Business Review
6. Deane F. Johnson Center Receives Ronald and Nancy Reagan Award
7. VIDEO from Medialink and Johnson & Johnson: From Molecule to Medicine
8. Johnson & Johnson to Participate in Morgan Stanley Conference
9. Robert Wood Johnson Foundation Partners with AACN to Launch New Careers in Nursing Scholarship Program
10. UT Southwestern Medical Center receives grant from the Robert Wood Johnson Foundation
11. Johnson & Johnson to Webcast Annual Meeting of Shareholders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2016)... ... 04, 2016 , ... Fertility Centers of New England announced today the opening ... Fertility Center provides convenient access to care for patients seeking fertility treatment in Maine. ... Wellness Comprehensive Care in Portland,” said Fertility Centers of New England President and CEO, ...
(Date:5/3/2016)... ... May 04, 2016 , ... An ... is reaching the global health community through expanding activities that embrace training, standards, ... in the resource-limited countries. , In support of this important work, ...
(Date:5/3/2016)... ... 03, 2016 , ... Today at its Annual Technology & ... Pulido, R.Ph., Co-Founder of NCPDP and member of the NCPDP Foundation Board of ... Specialist, Office of the National Coordinator for Health Information Technology (ONC). NCPDP’s Champion ...
(Date:5/3/2016)... ... 2016 , ... Calvary Hospital recently hosted a reception to mark a new ... located at Mary, Manning Walsh Home (MMW) in Manhattan. , During the school ... an hour, once a week. The music brings a lot of joy to the ...
(Date:5/3/2016)... ... 03, 2016 , ... Sandbox, one of the nation’s leading ... the newly created position of executive vice president, chief creative officer.     , In ... Chicago and LA offices. He reports to Nancy Finigan, president of those offices. ...
Breaking Medicine News(10 mins):
(Date:5/3/2016)... 2016   BIOTRONIK will be exhibiting and ... the implant at the Heart Rhythm Society,s 37 th ... San Francisco . "Physicians and ... of patient care and satisfaction possible. Part of that ... every tomorrow," said Marlou Janssen , President, BIOTRONIK, ...
(Date:5/3/2016)... 2016 Intec Pharma Ltd. (NASDAQ: ... company, today announced the appointment of Pnina Strauss-Levy ... "Ms. Strauss-Levy has 15 years of experience in ... outstanding track record, having supported the advancement of several ... in the United States and ...
(Date:5/2/2016)... Leading Economies with Fastest Real GDP Annual Percentage Change, ... 8 Ireland 7.8 India 7.3, , Source: IMF and TechSci ... comprises of Brazil , Russia , ... Africa , registered the fastest GDP growth during the first decade of ... , recession in Brazil and Russia ...
Breaking Medicine Technology: